2023-04-012024-03-312024-03-31false07190503Dust In The Blood2024-08-1459113iso4217:GBPxbrli:pure071905032023-04-01071905032024-03-31071905032023-04-012024-03-31071905032022-04-01071905032023-03-31071905032022-04-012023-03-3107190503bus:SmallEntities2023-04-012024-03-3107190503bus:AuditExempt-NoAccountantsReport2023-04-012024-03-3107190503bus:FullAccounts2023-04-012024-03-3107190503bus:PrivateLimitedCompanyLtd2023-04-012024-03-3107190503core:WithinOneYear2024-03-3107190503core:AfterOneYear2024-03-3107190503core:WithinOneYear2023-03-3107190503core:AfterOneYear2023-03-3107190503core:ShareCapital2024-03-3107190503core:SharePremium2024-03-3107190503core:RevaluationReserve2024-03-3107190503core:OtherReservesSubtotal2024-03-3107190503core:RetainedEarningsAccumulatedLosses2024-03-3107190503core:ShareCapital2023-03-3107190503core:SharePremium2023-03-3107190503core:RevaluationReserve2023-03-3107190503core:OtherReservesSubtotal2023-03-3107190503core:RetainedEarningsAccumulatedLosses2023-03-3107190503core:LandBuildings2024-03-3107190503core:PlantMachinery2024-03-3107190503core:Vehicles2024-03-3107190503core:FurnitureFittings2024-03-3107190503core:OfficeEquipment2024-03-3107190503core:NetGoodwill2024-03-3107190503core:IntangibleAssetsOtherThanGoodwill2024-03-3107190503core:ListedExchangeTraded2024-03-3107190503core:UnlistedNon-exchangeTraded2024-03-3107190503core:LandBuildings2023-03-3107190503core:PlantMachinery2023-03-3107190503core:Vehicles2023-03-3107190503core:FurnitureFittings2023-03-3107190503core:OfficeEquipment2023-03-3107190503core:NetGoodwill2023-03-3107190503core:IntangibleAssetsOtherThanGoodwill2023-03-3107190503core:ListedExchangeTraded2023-03-3107190503core:UnlistedNon-exchangeTraded2023-03-3107190503core:LandBuildings2023-04-012024-03-3107190503core:PlantMachinery2023-04-012024-03-3107190503core:Vehicles2023-04-012024-03-3107190503core:FurnitureFittings2023-04-012024-03-3107190503core:OfficeEquipment2023-04-012024-03-3107190503core:NetGoodwill2023-04-012024-03-3107190503core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3107190503core:ListedExchangeTraded2023-04-012024-03-3107190503core:UnlistedNon-exchangeTraded2023-04-012024-03-3107190503core:MoreThanFiveYears2023-04-012024-03-3107190503core:Non-currentFinancialInstruments2024-03-3107190503core:Non-currentFinancialInstruments2023-03-3107190503dpl:CostSales2023-04-012024-03-3107190503dpl:DistributionCosts2023-04-012024-03-3107190503core:LandBuildings2023-04-012024-03-3107190503core:PlantMachinery2023-04-012024-03-3107190503core:Vehicles2023-04-012024-03-3107190503core:FurnitureFittings2023-04-012024-03-3107190503core:OfficeEquipment2023-04-012024-03-3107190503dpl:AdministrativeExpenses2023-04-012024-03-3107190503core:NetGoodwill2023-04-012024-03-3107190503core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3107190503dpl:GroupUndertakings2023-04-012024-03-3107190503dpl:ParticipatingInterests2023-04-012024-03-3107190503dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3107190503core:ListedExchangeTraded2023-04-012024-03-3107190503dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3107190503core:UnlistedNon-exchangeTraded2023-04-012024-03-3107190503dpl:CostSales2022-04-012023-03-3107190503dpl:DistributionCosts2022-04-012023-03-3107190503core:LandBuildings2022-04-012023-03-3107190503core:PlantMachinery2022-04-012023-03-3107190503core:Vehicles2022-04-012023-03-3107190503core:FurnitureFittings2022-04-012023-03-3107190503core:OfficeEquipment2022-04-012023-03-3107190503dpl:AdministrativeExpenses2022-04-012023-03-3107190503core:NetGoodwill2022-04-012023-03-3107190503core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3107190503dpl:GroupUndertakings2022-04-012023-03-3107190503dpl:ParticipatingInterests2022-04-012023-03-3107190503dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3107190503core:ListedExchangeTraded2022-04-012023-03-3107190503dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3107190503core:UnlistedNon-exchangeTraded2022-04-012023-03-3107190503core:NetGoodwill2024-03-3107190503core:IntangibleAssetsOtherThanGoodwill2024-03-3107190503core:LandBuildings2024-03-3107190503core:PlantMachinery2024-03-3107190503core:Vehicles2024-03-3107190503core:FurnitureFittings2024-03-3107190503core:OfficeEquipment2024-03-3107190503core:AfterOneYear2024-03-3107190503core:WithinOneYear2024-03-3107190503core:ListedExchangeTraded2024-03-3107190503core:UnlistedNon-exchangeTraded2024-03-3107190503core:ShareCapital2024-03-3107190503core:SharePremium2024-03-3107190503core:RevaluationReserve2024-03-3107190503core:OtherReservesSubtotal2024-03-3107190503core:RetainedEarningsAccumulatedLosses2024-03-3107190503core:NetGoodwill2023-03-3107190503core:IntangibleAssetsOtherThanGoodwill2023-03-3107190503core:LandBuildings2023-03-3107190503core:PlantMachinery2023-03-3107190503core:Vehicles2023-03-3107190503core:FurnitureFittings2023-03-3107190503core:OfficeEquipment2023-03-3107190503core:AfterOneYear2023-03-3107190503core:WithinOneYear2023-03-3107190503core:ListedExchangeTraded2023-03-3107190503core:UnlistedNon-exchangeTraded2023-03-3107190503core:ShareCapital2023-03-3107190503core:SharePremium2023-03-3107190503core:RevaluationReserve2023-03-3107190503core:OtherReservesSubtotal2023-03-3107190503core:RetainedEarningsAccumulatedLosses2023-03-3107190503core:NetGoodwill2022-04-0107190503core:IntangibleAssetsOtherThanGoodwill2022-04-0107190503core:LandBuildings2022-04-0107190503core:PlantMachinery2022-04-0107190503core:Vehicles2022-04-0107190503core:FurnitureFittings2022-04-0107190503core:OfficeEquipment2022-04-0107190503core:AfterOneYear2022-04-0107190503core:WithinOneYear2022-04-0107190503core:ListedExchangeTraded2022-04-0107190503core:UnlistedNon-exchangeTraded2022-04-0107190503core:ShareCapital2022-04-0107190503core:SharePremium2022-04-0107190503core:RevaluationReserve2022-04-0107190503core:OtherReservesSubtotal2022-04-0107190503core:RetainedEarningsAccumulatedLosses2022-04-0107190503core:AfterOneYear2023-04-012024-03-3107190503core:WithinOneYear2023-04-012024-03-3107190503core:Non-currentFinancialInstrumentscore:CostValuation2023-04-012024-03-3107190503core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-012024-03-3107190503core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-012024-03-3107190503core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-012024-03-3107190503core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-012024-03-3107190503core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-012024-03-3107190503core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3107190503core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3107190503core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3107190503core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3107190503core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3107190503core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3107190503core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3107190503core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3107190503core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3107190503core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3107190503core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3107190503core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3107190503core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3107190503core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3107190503core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3107190503core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3107190503core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3107190503core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3107190503core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3107190503core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3107190503core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3107190503bus:Director12023-04-012024-03-31

Dust In The Blood

Registered Number
07190503
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2024

Dust In The Blood
Company Information
for the year from 1 April 2023 to 31 March 2024

Director

O'Neill, Lesley Clare

Registered Address

The Station
77 Canal Road
Leeds
LS12 2LX

Registered Number

07190503 (England and Wales)
Dust In The Blood
Balance Sheet as at
31 March 2024

Notes

2024

2023

£

£

£

£

Current assets
Debtors3800900
Cash at bank and on hand407,545357,220
408,345358,120
Creditors amounts falling due within one year4(35,310)(27,504)
Net current assets (liabilities)373,035330,616
Total assets less current liabilities373,035330,616
Net assets373,035330,616
Capital and reserves
Called up share capital100100
Profit and loss account372,935330,516
Shareholders' funds373,035330,616
The financial statements were approved and authorised for issue by the Director on 14 August 2024, and are signed on its behalf by:
O'Neill, Lesley Clare
Director
Registered Company No. 07190503
Dust In The Blood
Notes to the Financial Statements
for the year ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for services rendered, stated net of discounts and of Value Added Tax.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
2.Average number of employees

20242023
Average number of employees during the year00
3.Debtors: amounts due within one year

2024

2023

££
Prepayments and accrued income800900
Total800900
4.Creditors: amounts due within one year

2024

2023

££
Taxation and social security30,99223,338
Other creditors818666
Accrued liabilities and deferred income3,5003,500
Total35,31027,504